Myeloid-derived suppressor cells inhibit T cell ... - Springer Link
Recommend Documents
1Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA ... One of the responses of the tumor host to hypoxic conditions.
... Apolloni, Paolo Serafini, Paola. Alessandra Mazzoni, Vincenzo Bronte, Alberto Visintin, ..... Several kinases, including members of the JAK family,. FIGURE 5.
magglutinin. (PHA) mitogenic response; however, pu- rifled. CD4 or CD8. T cells exhibit a statistically normal mitogenic function. Furthermore, no T cell inhibitory.
Jun 5, 2011 - Monocytic. MDSCs express the same markers but have lower levels of ...... Becerra CR, Fishman M, Antonia S, Sporn MB, Liby KT, Rawal B,.
1 Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7 ... Adoptive immunotherapy with lymphokine-ac-.
J. A. Zack. Division of Hematology-Oncology ,. David Geffen School of .... J.A. Zack and D.N. Vatakis ..... Martin MA (2009) High frequencies of resting CD4+.
Dec 13, 2010 - C57BL/6 mice inhibited DCOVA-stimulated in vitro CD4+ T-cell proliferation ... CD41 T-cell EXO on CD81 CTL-mediated antitumor immunity.
May 27, 2011 - the functional roles of physical cross-junctional adhesion between T and DC in shaping T cell responses. In addition, the mechanisms.
Myeloid-derived suppressor cells inhibit T cell ... - Springer Link
Oct 23, 2015 - in human extranodal NK/T cell lymphoma: a novel prognostic indicator .... of many types of tumors, including multiple myeloma [6,. 7]. MDSCs ... diagnosed with ENKL, and the lymphoma involved nasal and paranasal lesions ...
Cancer Immunol Immunother (2015) 64:1587–1599 DOI 10.1007/s00262-015-1765-6
ORIGINAL ARTICLE
Myeloid‑derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator Han Zhang1,2,3 · Ze‑Lei Li1,2,3 · Shu‑Biao Ye1,2,3 · Li‑Ying Ouyang1,2,5 · Yu‑Shan Chen1,2,6 · Jia He1,2,3 · Hui‑Qiang Huang1,2,4 · Yi‑Xin Zeng1,2 · Xiao‑Shi Zhang1,2,3 · Jiang Li1,2,3
Abstract The expansion of myeloid-derived suppressor cells (MDSCs) and its correlation with advanced disease stage have been shown in solid cancers. Here, we investigated the functional features and clinical significance of MDSCs in extranodal NK/T cell lymphoma (ENKL). A higher percentage of circulating HLA-DR−CD33+CD11b+ MDSCs was observed in ENKL patients than in healthy controls (P 60 %) and CD15+ granulocytic (PMN-MDSCs, 60 %), and the CD15+ PMN-MDSC subset represented approximately 20 % of the MDSC population of ENKL patients. The proportion of Mo-MDSCs and PMN-MDSCs in the peripheral blood of ENKL patients was significantly different to that of healthy donors (P
